---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-092661"
form_type: "8-K"
ticker: "APM"
cik: "0001734005"
company_name: "Aptorum Group Ltd"
filed_at: "2026-08-21T21:00:33+00:00"
generated_at: "2026-08-21T21:02:28.673058+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# Niki BioSolutions posts H1 2026 net loss of $1.3M, flags going-concern doubt

## Summary
- H1 2026 net loss attributable to Niki was $1,326,004 vs $441,780 in H1 2025; EPS loss of $1.6.
- Cash fell to $1,834,171 from $3,452,891 at Dec 31, 2025; operating cash outflow of $1,553,720.
- Management disclosed substantial doubt about going concern within next 12 months; negative working capital of $2,475,418.
- R&D expenses rose to $383,752 from $19,375 in H1 2025; related-party convertible notes total $3,508,500.
- 1-for-10 reverse stock split effective July 20, 2026; 1,979,216 shares issued to DiamiR stockholders.

## SEC filing metadata
- accession: 0001213900-26-092661
- form_type: 8-K
- ticker: APM
- cik: 0001734005
- company_name: Aptorum Group Ltd
- filed_at: 2026-08-21T21:00:33+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1734005/000121390026092661/0001213900-26-092661-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1734005/000121390026092661/ea0302544-8k_nikibio.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-092661
- JSON: https://secwatch.observer/filing/0001213900-26-092661.json
- Plain text: https://secwatch.observer/filing/0001213900-26-092661.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.